Apollo Hospitals Stock Trades As Top Nifty Gainer On Q1 Performance

The stock of healthcare sector, Apollo Hospitals surged nearly 3 per cent to top in the benchmark index, Nifty after the firm posted roust Q1 earnings.

Apollo Hospitals stock traded with 2.1 per cent gain at Rs 6,729 in the afternoon session on the National Stock Exchange (NSE). 

Apollo Hospitals’ consolidated net profit for the company in Q1 of FY25 increased by 83 per cent year-on-year (YoY) to Rs 305 crore from Rs 167 crore in the same period the previous year.

The previous quarter's revenue from operations increased by 15 per cent to Rs 5,086 crore, while in the corresponding quarter of the previous fiscal year, the company recorded a topline of Rs 4,418 crore.

Aside from the operational achievement, Q1's EBITDA margin increased to 13.3 per cent.

As per the Nuvama brokerage expectations, Apollo Hospitals was expected to generate a combined net profit of Rs 295 crore in the first quarter of the fiscal year, on revenue of Rs 5,128 crore.

Besides, revenue growth in all of Apollo's categories increased by 15 per YoY, contributing to the company's strong profitability.

The company's pharmacy, diagnostics, retail healthcare, and Apollo 24/7 divisions, together with Apollo Health and Lifestyle and Apollo HealthCo were able to maintain profitability at the EBITDA level. But in terms of net profit, they failed to break even.

With a significant increase in patient flows, the company's main healthcare services division saw an increase in overall occupancy to 68 per cent from 62 per cent a year earlier.

In terms of stock performance, Apollo Hospitals stock delivered 17 per cent returns in 2024 so far, while the sectoral index, Nifty Pharma soared 30 per cent year-to-date (YTD).